Humacyte (HUMA)
NASDAQ:HUMA
Want to see HUMA full AI Analyst Report?
Humacyte (HUMA) Ownership Overview
9.88% Insiders
5.22% Mutual Funds
6.35% Other Institutional Investors
7.85% ETFs
70.70% Public Companies and
Individual Investors
The ownership structure of Humacyte (HUMA) stock is a mix of institutional, retail, and individual investors. Approximately 19.42% of the company’s stock is owned by Institutional Investors, 9.88% is owned by Insiders, and 70.70% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
May 20, 2026 | xxxxxxxxxxxxx | $9790 | |
May 20, 2026 | xxxxxxxxxxxxx | $50000 | |
Aug 20, 2025 | xxxxxxxxxxxxx | $3733191 | |
Aug 20, 2025 | xxxxxxxxxxxxx | $3733191 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2024 | xxxxxxxxxxxxx | $3468593 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $1213565 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 18,312,735 | Insider | 8.25% | 19,228,372 | |
| 8,413,301 | Institution | 3.79% | 8,833,966 | |
| 7,571,487 | Institution | 3.41% | 7,950,061 | |
| 5,834,076 | Institution | 2.63% | 6,125,780 | |
| 5,723,750 | Institution | 2.58% | 6,009,938 | |
| 2,002,582 | Institution | 0.90% | 2,102,711 | |
| 1,694,728 | Institution | 0.76% | 1,779,464 | |
| 1,392,091 | Insider | 0.63% | 1,461,696 | |
| 1,392,091 | Insider | 0.63% | 1,461,696 | |
| 1,123,533 | Institution | 0.51% | 1,179,710 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,834,076 | Institution | 2.63% | 6,125,780 | |
| 1,694,728 | Institution | 0.76% | 1,779,464 | |
| 1,123,533 | Institution | 0.51% | 1,179,710 | |
| 896,941 | Institution | 0.40% | 941,788 | |
| 478,723 | Institution | 0.22% | 502,659 | |
| 433,550 | Institution | 0.20% | 455,228 | |
| 322,544 | Institution | 0.15% | 338,671 | |
| 210,000 | Institution | 0.09% | 220,500 | |
| 104,939 | Institution | 0.05% | 110,186 | |
| 70,822 | Institution | 0.03% | 74,363 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,295,966 | Institution | 2.39% | 3,213,063 | |
| 3,891,487 | Institution | 1.75% | 3,541,253 | |
| 1,699,510 | Institution | 0.77% | 1,031,093 | |
| 1,413,353 | Institution | 0.64% | 1,286,151 | |
| 1,103,323 | Institution | 0.50% | 1,004,024 | |
| 800,376 | Institution | 0.36% | 485,588 | |
| 740,137 | Institution | 0.33% | 740,137 | |
| 476,743 | Institution | 0.21% | 289,240 | |
| 410,830 | Institution | 0.19% | 373,855 | |
| 261,403 | Institution | 0.12% | 237,877 |
FAQ
Who Owns Humacyte (HUMA)?
According to the latest TipRanks data, approximately 6.35% of the company's stock is held by institutional investors, 9.88% is held by insiders, and 70.70% is held by retail investors.
What percentage of Humacyte (HUMA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 6.35% of Humacyte (HUMA) stock is held by institutional investors.
What percentage of Humacyte (HUMA) stock is held by retail investors?
According to the latest TipRanks data, approximately 70.70% of Humacyte (HUMA) stock is held by retail investors.
Who owns the most shares of Humacyte (HUMA)?
FRESENIUS MEDICAL CARE HOLDINGS INC NY owns the most shares of Humacyte (HUMA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.